| Day 1, Thursday, May 15th | |
|---|---|
| 08:15-08:30 | Welcome Coffee |
| 08:30-08:50 | COMy 2025 kick-off |
| 08:50-10:20 | Session 1: Advances in biology I |
| 10:20-11:20 | Session 2: IMS Session |
| 11:20-11:40 | Coffee Break |
| 11:40-13:10 | Session 3: How do I assess? |
| 13:10-13:40 | Lunch Break |
| 13:40-15:10 | Opposite sides of the spectrum: individualising treatment from the fittest to the frailest in NDMM Industry-supported Lunch Symposium by J&J |
| 15:10-15:20 | Technical Break |
| 15:20-16:20 | Session 4: Advances in biology II |
| 16:20-16:40 | Coffee Break |
| 16:40-18:10 | Unmet Needs in Relapsed/Refractory Multiple Myeloma: Considering a BCMA-Directed Bispecific Industry-supported Afternoon Symposium by Pfizer |
| 18:10-18:20 | Technical Break |
| 18:20-19:00 | Session 5: Plenary lectures I |
| 19:00-19:30 | Session 6: The COMy Debate: treatment of smoldering myeloma |
| 19:30 | Welcome Reception |
| Day 2, Friday, May 16th | |
|---|---|
| 07:30-08:15 | The Trinity – The balance of Safety, Efficacy, and Quality of Life in TCR RRMM treatment Industry-supported Breakfast Symposium by Oncopeptides |
| 08:15-08:25 | Technical Break |
| 08:25-09:35 | Session 7: How do I treat? Part I |
| 09:35-09:55 | Coffee Break |
| 09:55-11:25 | Unlocking the future of T cell therapies: advancing innovation and optimising impact Industry-supported Morning Symposium by J&J |
| 11:25-11:35 | Technical Break |
| 11:35-12:20 | Session 8 |
| 12:20-12:50 | Lunch Break |
| 12:50-14:20 | A puzzle in progress: Piecing together clinical trial data in NDMM Industry-supported Lunch Symposium by Sanofi |
| 14:20-14:30 | Technical Break |
| 14:30-15:15 | Session 9: Next generation CAR-T cells |
| 15:15-16:00 | Session 10: Plenary lectures II |
| 16:00-16:20 | Coffee Break |
| 16:20-17:50 | Innovations in Relapsed Refractory Multiple Myeloma Care: Debating the Future of Treatment Strategies Industry-supported Afternoon Symposium by BMS |
| 17:50-18:00 | Technical Break |
| 18:00-19:00 | Session 11: Treatment of relapsed/refractory disease |
| 19:00-19:30 | COMy Award Ceremony |
| Day 3, Saturday, May 17th | |
|---|---|
| 08:15-08:30 | Good-Morning Coffee |
| 08:30-10:20 | Session 12: The ideal trial on the road to achieve the best outcome for patients |
| 10:20-10:35 | Coffee Break continued … |
| 10:35-11:50 | Clinical Application of clonoSEQ Testing in MM Industry-supported Morning Symposium Adaptive |
| 11:50-12:00 | Technical Break |
| 12:00-12:45 | Session 13: Hot topics |
| 12:45-13:15 | Lunch Break |
| 13:15-14:45 | Breaking barriers in myeloma: exploring the potential of antibody drug conjugates Industry-supported Lunch Symposium by GSK |
| 14:45-14:55 | Technical Break |
| 14:55-16:10 | Session 14: How do I treat? Part II |
| 16:10-16:30 | Coffee Break |
| 16:30-17:15 | Session 15: Treatment of advanced relapse: beyond immunotherapy |
| 17:15-18:25 | Session 16: IACH special session |
| 18:25-19:20 | Session 17: Keynote lectures |
| 19:20-19:30 | COMy In-Person Conclusions |
| Day 4, Sunday, May 18th – ONLINE ONLY | |
|---|---|
| 10:00-11:30 | Multiple Myeloma Communications I |
| Break | |
| 11:40-12:45 | Multiple Myeloma Communications II |
| Conclusion and see you next year! | |
